3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Breast Neoplasms
8
Polycystic Ovary Syndrome
5
Multiple Myeloma
5
Prostatic Neoplasms
4
Neoplasm Metastasis
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Venous Thromboembolism
1
Urinary Bladder Neoplasms
1
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Thrombosis
1
Smoldering Multiple Myeloma
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Rectal Neoplasms
1
Perioperative Inflammatory Response
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neurotoxicity Syndromes
1
Interventions
Cyclophosphamide
6
Granulocyte Colony-Stimulating Factor
5
Melphalan
4
Etoposide
4
Cisplatin
4
Carboplatin
4
sodium thiosulfate
3
fludarabine
3
Thiotepa
3
Mesna
3
Filgrastim
3
Busulfan
3
pembrolizumab
2
Vorinostat
2
Vincristine
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Ifosfamide
2
Gemcitabine
2
Fluorouracil
2
Doxorubicin
2
talazoparib
1
sintilimab
1
sargramostim
1
pegylated granulocyte colony-stimulating factor
1
omburtamab I-131
1
lenvatinib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
etoposide phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hepatoblastoma
×
Simvastatin
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled